Canaccord Adams initiates coverage on several Life Sciences stocks:

Allos Therapeutics (Nasdaq: ALTH): Pralatrexate opportunity priced to perfection; initiating ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE